1. NCCN Guidelines® Insights: ovarian cancer, version 3.2022;Armstrong;J Natl Compr Canc Netw,2022
2. NCCN Guidelines® Insights: hematopoietic growth factors, version 1.2022;Griffiths;J Natl Compr Canc Netw,2022
3. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer;Guastalla;Br J Cancer,2003
4. First-in-human trial of a novel anti-trop-2 antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the treatment of Diverse Metastatic Solid Tumors. Clinical cancer research : an official journal of the;Starodub;Am Assoc Cancer Res,2015
5. WHO International Standard Terminologies On Traditional Chinese medicine. In: Organization WH;Organization,2022